Ligand Pharmaceuticals
LGND
#4134
Rank
A$3.20 B
Marketcap
$166.43
Share price
-0.67%
Change (1 day)
54.52%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2024 (TTM): A$8.82 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.16 Billion. a decrease over its 2023 earnings that were of A$0.10 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2024

Annual earnings

Year Earnings Change
2024 A$8.73 M-91.37%
2023 A$0.10 B-7.59%
2022 A$0.10 B4%
2021 A$0.10 B296.42%
2020 A$26.56 M-97.97%
2019 A$1.30 B275.62%
2018 A$0.34 B237.48%
2017 A$0.10 B49.05%
2016 A$69.32 M55.41%
2015 A$44.6 M36.87%
2014 A$32.59 M29.59%
2013 A$25.14 M1309.35%
2012 A$1.78 M-43.97%
2011 A$3.18 M-113.19%
2010 -A$24.15 Million59.86%
2009 -A$15.11 Million-61.33%
2008 -A$39.07 Million-58.75%
2007 -A$94.7 Million20.52%
2006 -A$78.58 Million81.27%
2005 -A$43.35 Million
2003 -A$30.18 Million-20.6%
2002 -A$38.01 Million4.38%
2001 -A$36.41 Million-48.83%
2000 -A$71.15 Million-19.74%
1999 -A$88.65 Million-19.06%
1998 -A$0.11 Billion126.71%
1997 -A$48.32 Million-5.83%
1996 -A$51.31 Million136.23%
1995 -A$21.72 Million-33.97%
1994 -A$32.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$7.25 B 82,930.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$97.38 Million-1,214.77%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.91 B 79,066.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$33.37 B 381,939.27%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.48 B 200,098.16%๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.95 B 228,334.52%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$13.19 Billion-151,045.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.94 Billion-10,782.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.44 B 314,113.66%๐Ÿ‡บ๐Ÿ‡ธ USA